Haemonetics Corporation  

(Public, NYSE:HAE)   Watch this stock  
Find more results for HAE
+0.42 (1.05%)
Jan 13 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 39.89 - 40.74
52 week 25.98 - 41.41
Open 40.28
Vol / Avg. 178,861.00/297,439.00
Mkt cap 2.11B
P/E     -
Div/yield     -
EPS -1.16
Shares 51.66M
Beta 0.94
Inst. own 103%
Jan 30, 2017
Q3 2017 Haemonetics Corp Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Jan 12, 2017
Haemonetics Corp at JPMorgan Healthcare Conference
Nov 7, 2016
Q2 2017 Haemonetics Corp Earnings Release
Nov 7, 2016
Q2 2017 Haemonetics Corp Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '16) 2016
Net profit margin 9.00% -6.12%
Operating margin 11.26% -4.83%
EBITD margin - 17.12%
Return on average assets 6.00% -3.96%
Return on average equity 10.86% -7.18%
Employees 3,225 -
CDP Score - -


BRAINTREE, MA 02184-2412
United States - Map
+1-781-8487100 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company's segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The Company offers a range of blood management solutions. The Company has a suite of integrated software solutions, which include solutions for blood drive planning and blood collection.

Officers and directors

Christopher Simon President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
William P. Burke Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
Byron Selman President - Global Markets
Age: 49
Bio & Compensation  - Reuters
Sandra Jesse Executive Vice President, Chief Legal Officer
Age: 63
Bio & Compensation  - Reuters
Neil Ryding Executive Vice President, Global Operations
Age: 55
Bio & Compensation  - Reuters
Dan Goldstein Principal Accounting Officer, Vice President, Corporate Controller
Age: 39
Bio & Compensation  - Reuters
Richard J. Meelia Non-Executive Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Charles J. Dockendorff Independent Director
Age: 61
Bio & Compensation  - Reuters
Susan Bartlett Foote Independent Director
Age: 69
Bio & Compensation  - Reuters
Ronald G. Gelbman Independent Director
Age: 68
Bio & Compensation  - Reuters